Personalized Medicine: the impact of ferrofluids, clinical procedures, strategies, applications, challenges, current trends, and research opportunities.

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2026 | Volume : 3 | 02 | Page :
    By

    Gizachew Diga Milki,

  1. Associate Professor, Department of Physics, Jimma University, Ethiopia, Africa

Abstract

Personalized medicine has shown progressive development and evolution in health care systems. It is considered as transformative emerging medicine encorporating advanced technologies including genomics, AI as thinking partner, and nanotechnology in a greater extent. The quest for painless injection, lesstoxicity, rapid cell separation, and gene sequencing make ferrofluid the focus of personalized medicine. Currently, magnetic nanoparicles and ferrofluides are becoming driving force of personalized medicine. However, contronlling and managing nanoscale toxicity of magnetic nanoparticles and ferrofluids is challenging due to several factors. Thus, diagnosizing the underlying problems related to nanotoxicity effects, synthesis procedures, and design of magnetic nanoparticles and ferrofluids is primary important. This research, therefore delves into assessment of nanoscale properties and functionality of magnetic nanoparticles and ferrofluids for efficient personalized medicine.To this end, unrevaling the potential role of green synthesis methods, magnetic nanoparticles, and ferrfluids as therapeutic agent, diagnostic, and targeted drug delivery is visualized. A strategies such a streamlined approach, pharmacologices, genometic & AI technologies, are proposed to resolve the major challenges encountered in accelerating the research and developments in personalized medicine. Moreovers, the research acces the current trends, emerging technologies, and research progress involving ferrofluids and development of personalized medicine is focused.

Keywords: personalized medicine, magnetic nanoparticles, ferrofuilds , streamlime approach, emerging technologies.

How to cite this article:
Gizachew Diga Milki. Personalized Medicine: the impact of ferrofluids, clinical procedures, strategies, applications, challenges, current trends, and research opportunities.. Emerging Trends in Personalized Medicines. 2026; 03(02):-.
How to cite this URL:
Gizachew Diga Milki. Personalized Medicine: the impact of ferrofluids, clinical procedures, strategies, applications, challenges, current trends, and research opportunities.. Emerging Trends in Personalized Medicines. 2026; 03(02):-. Available from: https://journals.stmjournals.com/etpm/article=2026/view=248024


References

1. Prakash A. Advances in Personalized Medicine: Implications for Healthcare. Journal of Medicine and Medical Sciences . 2024, Vol. 15, Issue 5, DOI: 10.14303/2141-9477.2024.112.
2. Stefanicka-Wojtas D, Kurpas D. Personalised Medicine-Implementation to the Healthcare System in Europe (Focus Group Discussions). J Pers Med. 2023 Feb 21;13(3):380. doi: 10.3390/jpm13030380.
3. Taherdoost H., and Ghofrani A., AI’s role in revolutionizing personalized medicine by reshaping pharmacogenomics and drug therapy. Intelligent Pharmacy, 2024, Vol. 2, 5 Pages, 643-650.
4. Cutter GR, Liu Y. Personalized medicine: The return of the house call? Neurol Clin Pract. 2012 Dec;2(4):343-351. doi: 10.1212/CPJ.0b013e318278c328.
5. Mehta, M., Bhandari, A. Advancement in biomedical applications of ferrofluids. J Braz. Soc. Mech. Sci. Eng. 47, 490 (2025). https://doi.org/10.1007/s40430-025-05806-4
6. Buzdin A. Molecular Pathway Analysis Using High-Throughput OMICS Molecular Data. Academic press. Elsevier, 2024, 1st edt., ISBN: 9780443155680.

7. NHS, England, Medical directorate, medicine, diagnosis and personalized Medicine, Policy Unit, Ellen Graham, 7 September, (2016), 18 pages.
8. Issa AM. Personalized medicine and the practice of medicine in the 21st century. Mcgill J Med. 2007 Jan;10 (1): 53 -7.
9. Junaid SB, Imam AA, Balogun AO, De Silva LC, Surakat YA, Kumar G, Abdulkarim M, Shuaibu AN, Garba A, Sahalu Y, Mohammed A, Mohammed TY, Abdulkadir BA, Abba AA, Kakumi NAI, Mahamad S. Recent Advancements in Emerging Technologies for Healthcare Management Systems: A Survey. Healthcare (Basel). 2022 Oct 3;10(10):1940. doi:10.3390/healthcare10101940.

10. Amine, Bahhou. “The Power of Molecular Diagnosis in Modern Medicine” J Mol Genet Med 19 (2025): 712.ISSN: 1747-0862
11. Brunel University London. (2024, March 08).What is personalised medicine? Challenges, benefits, future. Life Sciences. https://www.brunel.net/en/blog/life-sciences/personalised- medicine.

12. Ruan Q. et al. Digital-WGS: Automated, highly efficient whole-genome sequencing of single cells by digital microfluidics. Science Advances 9 Dec 2020 Vol 6, Issue 50. DOI: 10.1126/sciadv.abd64

13. Perez-Riverol, Y. et al. Open-Source and FAIR Research Software for Proteomics.J. Proteome Res. 2025, 24 (5), 2222–2234. https://doi.org/10.1021/acs.jproteome.4c01079
14. Jamalinia M, Weiskirchen R. Advances in personalized medicine: translating genomic insights into targeted therapies for cancer treatment. Ann Transl Med. 2025 Apr 30;13(2):18. doi: 10.21037/atm-25-34.

15. Mishra PK, Raghuram GV, Bhargava A, Pathak N. Translation research in molecular disease diagnosis: bridging gap from laboratory to practice. J Glob Infect Dis. 2011 Apr;3(2):205-6. doi: 10.4103/0974-777X.81705.

16. Ng K, Sun J, Hu J, Wang F. Personalized Predictive Modeling and Risk Factor Identification using Patient Similarity. AMIA Jt Summits Transl Sci Proc. 2015 Mar 25;2015:132-6.
17. Sassi Z, Eickmann S, Roller R, Osmanodja B, Burchardt A, Tretter M, Samhammer D, Dabrock P, Möller S, Budde K, Herrmann A. Human-centered AI in healthcare: empowering patients and support persons in clinical decision-making. BMC Med Inform Decis Mak. 2025 Nov 26;
25(1):431. doi: 10.1186/s12911-025-03298-9.
18. Nassar M. Streamlining drug development with conversational AI-powered knowledge graphs: From preclinical discovery to clinical trials. F1000 Research, 2024, 13:1553. https://doi.org/10.7490/f1000research.1120065.1
19. Mariacristina Gagliard, et al. Molecularly Imprinted Biodegradable Nanoparticles. Scientific Report. 2017,7(1):40046. Doi. 10.1038//srep/ 40046.
20. Popova V, Dmitrienko E, Chubarov A. Magnetic nanocomposites and Imprinted Polymers for biomedical applications of Nucleic Acids. Magnetochemistry. 2023; 9(1):12. https://doi.org/10.3390/magnetochemistry9010012.
21. Golubnitschaja O, Kinkorova J, Costigliola V. Predictive, Preventive and Personalised Medicine as the hardcore of ‘Horizon 2020’: EPMA position paper. EPMA J. 2014 Apr 7;5(1):6. doi: 10.1186/1878-5085-5-6.

22. Na Duma, T., Humaidi, S., Hamid, M., Amiruddin, E., Rianna, M., & Novita, N. (2024). Enhanced Cancer Biomarker Detection using Fe3O4 Magnetic Nanoparticles: Synthesis, Surface Modifications and Diagnostic Applications: A Review. Trends in Sciences, 21(11), 8519. https://doi.org/10.48048/tis.2024.8519.
23. Hopkins CE. Emerging technologies in personalized medicine. Mol Aspects Med. 2023 Jun;91:101182. doi: 10.1016/j.mam.2023.101182.

24. Bloxham, Kenny. “A new era for Healthcare Communications: Introducing Webex Connect for healthcare.” Webex CPaaS Solutions, 25 Feb. 2025, https://cpaas.webex.com/blog/a-new-era- for-healthcare-communications-introducing-webex-connect-for-healthcare.

25. Alghamdi, M.A.; Fallica, A.N.; Virzì, N.; Kesharwani, P.; Pittalà, V.; Greish, K. The Promise of Nanotechnology in Personalized Medicine. J. Pers. Med. 2022, 12, 673.
https://doi.org/10.3390/jpm.12050673.
26. Man Y., et al. Organoids-On-a-Chip for Personalized Precision Medicine. Advanced Healthcare Materials. 2024, Vol. 13, Issue -30, https://doi.org/10.1002/adhm.202401843.
27. Goetz LH, Schork NJ. Personalized medicine: motivation, challenges, and progress. Fertil Steril. 2018 Jun;109(6):952-963. doi: 10.1016/j.fertnstert.2018.05.006.
28. Riemann, L.T., Ataian, M., Hähner, F.P.S. et al. Streamlining and Accelerating the Molecular Tumor Board Process at the University Medical Center Hamburg-Eppendorf. Targ Oncol 20, 725– 735 (2025). https://doi.org/10.1007/s11523-025-01160-6
29. Minuti AE, Stoian G, Herea DD, Radu E, Lupu N, Chiriac H. Fe-Cr-Nb-B Ferrofluid for Biomedical Applications. Nanomaterials (Basel). 2022 Apr 27;12(9):1488. doi:
10.3390/nano12091488.
30. Gawad, C., Koh, W. & Quake, S. Single-cell genome sequencing: current state of the science. Nat Rev Genet 17, 175–188 (2016). https://doi.org/10.1038/nrg.2015.16
31. Patel.h H. Ferrofluid and cancer, Medical life science, News letter. 2019.
32. Hayashi K et al. Smart Ferrofluid with Quick Gel Transformation in Tumors for MRI-Guided Local Magnetic Thermochemotherapy. Advanced functional materials. 2016, 11, 26, ISSN Pages 1708-1718. https://doi.org/10.1002/adfm.201504215
33. Nowak-Jary, J.; Machnicka, B. Toxicity of Magnetic Nanoparticles in Medicine: Contributing Factors and Modern Assessment Methods. Int. J. Mol. Sci. 2025, 26, 8586. https://doi.org/10.3390/ijms26178586.
34. Guan W, Gao H, Liu Y.Sun S. Li G. Application of magnetism in tissue regeneration: recent progress and future prospects, Regenerative Biomaterials, Volume 11, 2024, rbae048, https://doi.org/10.1093/rb/rbae048
35. European Society of Radiology (ESR). Medical imaging in personalised medicine: a white paper of the research committee of the European Society of Radiology (ESR). Insights Imaging. 2015 Apr;6(2):141-55. doi: 10.1007/s13244-015-0394-0.
36. Arndt N, Tran HDN, Zhang R, Xu ZP, Ta HT. Different Approaches to Develop Nanosensors for Diagnosis of Diseases. Adv Sci (Weinh). 2020 Oct 28;7(24):2001476. doi: 10.1002/advs.202001476.
37. Minuti AE, Stoian G, Herea DD, Radu E, Lupu N, Chiriac H. Fe-Cr-Nb-B Ferrofluid for Biomedical Applications. Nanomaterials (Basel). 2022 Apr 27;12(9):1488. doi:
10.3390/nano12091488.
38. Shi S, He S, Lin Q, Sun S. Magnetic Nanocomposite Hydrogels in Orthopedics: Applications and Perspectives. Int J Nanomedicine. 2025 Dec 20;20:15379-15394. doi: 10.2147/IJN.S539423.

39. Chang W, Meng Z, Zhao Y, Qi Y, Li Z, Lian H. Emerging Nanotechnology Strategies for Obesity Therapy. Adv Sci (Weinh). 2025 Aug;12(32):e01813. doi: 10.1002/advs.202501813.
40. Thwala LN, Ndlovu SC, Mpofu KT, Lugongolo MY, Mthunzi-Kufa P. Nanotechnology-Based Diagnostics for Diseases Prevalent in Developing Countries: Current Advances in Point-of-Care Tests. Nanomaterials (Basel). 2023 Mar 31;13(7):1247. doi: 10.3390/nano13071247.
41. Oehlsen O et al. Approaches on Ferrofluid Synthesis and Applications: Current Status and Future Perspectives. ACS Omega,. 2022, 7, 3134-3150. https://doi. Org/10. 1021/acsomega.1c05631.
42. Mukherjee S, Suleman S, Pilloton R, Narang J, Rani K. State of the Art in Smart Portable, Wearable, Ingestible and Implantable Devices for Health Status Monitoring and Disease Management. Sensors (Basel). 2022 Jun 1;22(11):4228. doi: 10.3390/s22114228.
43. Rachel Sasha. (2022). Wireless Health Monitoring Systems for Remote Patient Care Enabling Real-Time Data Transmission and Timely Medical Intervention. International Journal of Medical Electronics (IJME), 3(1), 1- 6.
44. Rasch, D., M. Privacy and Security in the world of Precision Medicine. GPSOLO. 2021, Vol – 38, No – 4, Page 54-55.
45. Prince W N 2nd , Cohen IG. Privacy in the age of medical big data. Nat Med. 2019 Jan; 25(1): 37-43. Doi: 10.1038/s41591-018-0272-7.
46. Yousuf, R., Fauzi, A., Akter, S., Azarisman, S., & Marzuki, O. (2010). Religious and Spiritual Beliefs and Practices in Medicine: An Evaluation in a Tertiary Care Hospital in Malaysia. Ibrahim Medical College Journal, 4(1), 4 – 8. https://doi.org/10.3329/imcj.v4i1.5927
47. Raza S. et al. he personalised medicine technology landscape. PHG Foundation, University of Cambridge, 2018,978-1-907198-31-1.
48. Houston L, Probst Y, Yu P, Martin A. Exploring Data Quality Management within Clinical Trials. Appl Clin Inform. 2018 Jan;9(1):72-81. doi: 10.1055/s-0037-1621702. Epub 2018 Jan 31.
49. Aghouzi, S. M. H., et al. Biosensing of single-nucleotide polymorphism: Technological advances and their transformative applications on health.Biosensors and Bioelectronics. 2025, 279, 117385. https://doi.org/10.1016/j.bios.2025.117385
50. Pacheco-Barrios K, Ortega-Márquez J, Fregni F. Haptic Technology: Exploring Its Underexplored Clinical Applications; A Systematic Review. Biomedicines. 2024; 12(12):2802. https://doi.org/10.3390/biomedicines12122802

Ahead of Print Subscription Review Article
Volume 03
02
Received 01/06/2026
Accepted 12/06/2026
Published 29/06/2026
Publication Time 28 Days
5

Login


My IP

PlumX Metrics